patients with vestibular schwannomas. 6, 7, 9, 23 Patients with these tumors typically undergo annual or biannual contrast-enhanced MRI for surveillance, leading to a higher exposure to gadolinium contrast. 6, 7, 9, 23 The purpose of this study was to determine whether a contrast-enhanced MRI protocol is more beneficial than a noncontrast MRI protocol that includes an MR cisternographic sequence in a large population of patients with vestibular schwannoma. Specifically, we sought to evaluate whether a conventional contrast-enhanced MRI protocol has any advantage compared to the noncontrast protocol for evaluating vestibular schwannoma size and intralesional characteristics such as cystic components or hemorrhage. In addition, we attempted to determine whether any potentially clinically significant incidental findings that would be identified with a contrast-enhanced MRI protocol might be missed with a noncontrast protocol.
Methods

Patient Cohort
This was a retrospective, IRB-approved study performed at a tertiary medical center (Massachusetts Eye & Ear Infirmary). A total of 278 patients with a diagnosis of vestibular schwannoma who underwent a temporal bone MRI examination with both a noncontrast, cisternographic and a conventional T1 postcontrast sequence between January 2000 and January 2016 were included in this study. This included a cohort previously described, with data collected before 2012, as well as the results of a search of our picture archiving and communication system (PACS) between 2012 and 2016 for patients with known diagnosis of vestibular schwannoma who had sequential scans that included postcontrast imaging as well as a cisternographic sequence.
13 Exclusion criteria included prior partial or complete resection of the vestibular schwannoma and motion or technical artifacts precluding a diagnostic assessment of the images. A total of 27 studies were excluded based on the aforementioned criteria, leading to the inclusion of 251 patients in the analysis. Basic patient descriptors, including age and sex, were recorded.
MRI Scanning Parameters
All scans performed prior to December 2006 were performed on a 1. 
Image Analysis
Evaluation of Vestibular Schwannoma Size
The images from each of the 251 cases were reviewed by a neuroradiology fellow, blinded to the patients' clinical history. For each patient, the MR cisternogram sequence and the postcontrast T1 sequence were obtained at the same time, and on the same scanner platform. The greatest transverse dimension of the vestibular schwannomas was measured on the noncontrast MRI sequences, specifically, on the MR cisternographic image. Six weeks following the initial evaluation on the noncontrast MR images, the greatest transverse dimension of the vestibular schwannoma was then measured only on the T1 postcontrast images (Fig. 1) . This separation in time between the evaluation of the MR cisternogram and T1 postcontrast images was done to minimize bias. This methodology is similar to that used in the study by Ozgen et al.
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Interrater variability was calculated for measurements of vestibular schwannoma size by comparing measurements performed by a neuroradiology fellow with those done by a head and neck radiology attending. A subset of 30 cases of vestibular schwannomas was reviewed independently by each rater. As before, initially only the cisternographic images were reviewed, then only the T1 postcontrast image at least 1 week later. The greatest measured transverse dimension of the vestibular schwannomas was recorded. This subset of 30 cases was used to perform interrater reliability derived from a power calculation performed by a biostatistician.
Evaluation of Vestibular Schwannoma Internal Characteristics
The vestibular schwannomas were assessed for the presence of internal cystic components, conventionally identified by focal T2 hyperintensity within the tumor or at the tumor periphery, and intralesional hemorrhage, as demonstrated by T1 signal intensity shortening within the tumor.
These findings were assessed on the noncontrast MR images first; then 6 weeks later, they were assessed on the postcontrast images. These results were recorded separately.
The sensitivity of the cisternographic sequence alone for the detection of cystic and hemorrhagic components was then calculated and compared to the performance of the postcontrast T1-weighted sequence, using the imaging appearance of the vestibular schwannoma on the conventional precontrast T1-weighted sequence and T2-weighted sequences as an internal reference.
Evaluation of Potentially Clinically Significant Incidental Findings
The last component of the imaging analysis included an assessment of potentially clinically significant incidental findings. Each of the 251 patient MRI examinations was reviewed for the presence of incidental findings, which while not relevant to the management of the vestibular schwannoma, might direct the patient to additional clinical evaluation or management.
Initially, the noncontrast MRI sequences including the MR cisternographic sequence were reviewed together. Six weeks later, the postcontrast sequences were reviewed for the same assessment.
The presence and type of incidental finding was recorded for each round of review. Each of the incidental findings was then assigned a clinical significance score as follows: 0 = no incidental findings, 1 = incidental findings of no clinical significance, 2 = incidental findings which require nonurgent follow-up, 3 = incidental findings which would require urgent/emergent management.
The number of incidental findings stratified by type and clinical significance score was recorded. Potentially clinically significant findings that could only be identified on postcontrast sequences were also noted.
Results
Patient Demographics
Of the 251 patients included in this study, 121 were male (48%) and 130 were female (52%). The patients' mean age was 54.7 ± 8.2 years. A total of 30 of these 251 patients (12%) had a diagnosis of neurofibromatosis type 2.
Vestibular Schwannoma Size and Interrater Reliability
On the cisternographic images, vestibular schwannomas ranged in size from 2 to 48 mm, with an average size of 15.07 ± 8.66 mm, compared to 15.08 ± 8.71 mm as measured on the postcontrast images (p = 0.99) ( Table 1) .
Interrater agreement for the evaluation of vestibular schwannoma size as measured on the MR cisternographic sequence was excellent (k = 0.89). Interrater agreement for the evaluation of vestibular schwannoma size as measured on the conventional postcontrast images was also excellent (k = 0.91). There was no statistically significant difference between vestibular schwannoma size measured on the MR cisternographic sequence and the size measured on the T1 postcontrast image (p = 0.77).
Evaluation of the Internal Components
A total of 45 of 251 (18%) vestibular schwannomas contained a presumed cystic component, ranging in size from 2 to 19 mm. Internal cystic components were best identified on the conventional T2-weighted images. A direct comparison of the MR cisternographic sequence to the conventional T2-weighted images noted that 39 of 45 cystic components were seen on the MR cisternographic sequence (86.7%).
When evaluating the presence of cystic components on the postcontrast T1-weighted images alone, only 11 cystic components were identified, compared to the 45 presumed cystic components seen on the conventional T2-weighted images, as well as 39 on the MR cisternographic sequence.
A total of 5 of the 251 vestibular schwannomas (0.02%) demonstrated intrinsic T1 hyperintense components that were attributed to possible intralesional hemorrhage (Fig.  2) . These presumed internal hemorrhagic components were only appreciated on the precontrast T1-weighted images, and could not be appreciated on the MR cisternographic sequences or the T1 postcontrast sequences.
Evaluation of Incidental Findings
Potentially clinically significant incidental findings were seen in a total of 80 patients (32%) ( Table 2 ). In the other 171 patients (68%), there were no clinically significant incidental findings (grade 0). A clinical significance score of 1 was given to findings in a total of 64 patients (25%), a score of 2 was given to findings in 8 patients (3%), and a score of 3 was given to findings in 2 patients (0.8%) ( Table 2) (Figs. 1 and 2 ). Findings for which clinical significance scores of 1 were given included paranasal sinus disease in 34 patients, chronic white matter disease in 18 patients, arachnoid cysts in 5 patients, meningiomas in 3 patients, Rathke's cleft cysts in 2 patients, and Tornwaldt cysts in 2 patients. A clinical significance score of 2 was given for pleomorphic parotid adenomas in 3 patients, a pituitary mass in 1 patient, a dural prostate cancer metastasis in 1 patient, labyrinthitis in 1 patient, and intracranial cavernous malformations 2 patients. A clinical significance score of 3 was given for the finding of demyelinating disease in 1 patient and acute-to-subacute pontine infarction in 1 patient (Fig. 3) . These potentially clinically significant incidental findings were identified on the review of the noncontrast sequences alone. There was no potentially clinically significant incidental finding identified on the postcontrast sequences that was not identified on the noncontrast MR sequences.
Discussion
The results of this study demonstrate that a noncontrast MRI protocol that includes an MR cisternographic sequence performs as well for the evaluation of vestibular schwannoma size as a conventional MRI protocol that includes postcontrast sequences. In addition, our analysis also showed that the noncontrast protocol performed as well as the conventional protocol for the detection of potentially clinically significant incidental findings. Moreover, the results of this study also demonstrated that intralesional characteristics of vestibular schwannomas, including cystic components and intralesional hemorrhage, are better assessed on the noncontrast MRI sequences. Based on these observations, the postcontrast imaging may not be needed in the setting of routine surveillance images for patients with vestibular schwannomas.
The findings from this study support the findings of prior studies demonstrating the high accuracy of the cisternographic sequence for the detection of vestibular schwannoma and characterization of lesion size. 1, 15, 19 This study builds on prior studies in demonstrating the low prevalence of clinically significant incidental findings and the lack of need for postcontrast imaging for the detection of these incidental findings. Further, the study shows a relatively high sensitivity of the cisternographic sequence for the detection of intralesional cystic components.
Based on the results of this study, we advocate for a noncontrast MRI protocol including the acquisition of an MR cisternographic sequence for the routine surveillance of vestibular schwannomas. The ability to shift to a surveillance protocol without the administration of intravenous MR contrast is clinically relevant, given recent concerns related to repeat administration of gadolinium-based contrast agents and reported deposition of gadolinium contrast in the brain parenchyma. 5, 11, 14, 21, 24 This is of particular concern in patients with vestibular schwannoma, given that surveillance examinations are routinely performed annually or biannually in this population. 6, 9, 16 Additionally, in a metric of decreasing scan time and healthcare costs, the acquisition of a shorter and more cost-effective noncontrast MRI sequence while maintaining an accurate assessment of lesion size and internal characteristics is of paramount importance. 2, 17, 22 At our institution, avoiding postcontrast imaging shortens the MRI acquisition time by approximately 8 minutes, eliminates the need for IV catheter placement prior to the study acquisition, and obviates the need for a serum laboratory workup to determine if a contrast agent may be administered.
In this study we looked at specific features of vestibular schwannomas, including size and internal signal characteristics. Each vestibular schwannoma was assessed based on images obtained during a single imaging session. We did not investigate recurrent vestibular schwannomas or interval growth of vestibular schwannomas. We looked at the presence of intralesional cystic components and intralesional hemorrhage as these have been reported as independent factors predicting the risk of rapid tumor growth and risk stratification for operative management of vestibular schwannomas. [2] [3] [4] [8] [9] [10] 12, 17, 18, 20, 22 There may be additional imaging features which impact clinical management that are not addressed in this study. Although this study was conducted in a large cohort of patients with vestibular schwannomas, the number of schwannomas that demonstrated intralesional hemorrhage was infrequent (5 patients). The cohort of patients included in this study had imaging performed on both 1.5-T and 3-T scanner platforms. While having a heterogeneous scanner platform is not ideal, the focus of this study was to evaluate various imaging characteristics of vestibular schwannomas as assessed on the MR cisternogram image compared to the postcontrast sequence acquired in the same patient. Therefore, for each patient, the MR cisternogram sequence and the postcontrast sequence were performed at the same time on the same scanner platform. A single, long-axis measurement of the vestibular schwannomas was performed in each case. While a 3D volumetric measurement may be more accurate, prior studies evaluating vestibular schwannoma size have used linear measurements. 19 Lastly, the results of this study pertain only to vestibular schwannomas within the internal auditory canal and cerebellopontine angle cisterns. We did not include intralabyrinthine vestibular schwannomas in this cohort as they constitute a rare presentation.
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Conclusions
The results of this study demonstrated no advantage of a postcontrast MRI protocol over a noncontrast MRI protocol that includes the acquisition of an MR cisternographic sequence for the evaluation of vestibular schwannoma size and internal cystic and hemorrhagic components. Furthermore, the results of this study suggest that no potentially clinically significant incidental findings would be missed with the elimination of a postcontrast sequence. Based on the results of this study, we recommend a noncontrast MR protocol with the inclusion of a cisternographic sequence for the serial follow-up evaluation of vestibular schwannomas, sparing these patients multiple doses of gadolinium contrast over the years.
